Neurocrine Biosciences (NBIX) Cost of Revenue (2017 - 2026)
Neurocrine Biosciences (NBIX) recorded Cost of Revenue of $26.6 million in Q3 2026, up 104.6% from $13 million a year earlier and up 14.7% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Cost of Revenue (2017 - 2026) Analysis & Trends
On a TTM basis, Neurocrine Biosciences' Cost of Revenue came in at $84.2 million as of Sep 30, 2026, up 101.4% year-over-year; for FY2025, it came in at $52.1 million, up 53.2% from FY2024.
- Annual Cost of Revenue has a five-year compound annual growth rate of 38.8% (FY2020 to FY2025).
- Across earlier years, Cost of Revenue came in at $34 million in FY2024 (-14.4%), $39.7 million in FY2023 (+71.1%), $23.2 million in FY2022 (+62.2%) and $14.3 million in FY2021 (+41.6%).
- The Q3 2026 figure is the highest quarterly Cost of Revenue in data going back to Q2 2017.
- On a year-over-year basis, Cost of Revenue has increased for eight consecutive quarters, with growth averaging 63.5% over the last eight quarters.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 139.6% in Q2 2023, against a decline of 28.6% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $23.2 million (Q2 2026), $13.8 million (Q1 2026) and $20.6 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.93 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.29 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 2.95 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.79 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.57 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.03 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 26.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 26.60 Mn |
| Jun 30, 2026 | 23.20 Mn |
| Mar 31, 2026 | 13.80 Mn |
| Dec 31, 2025 | 20.60 Mn |
| Sep 30, 2025 | 13.00 Mn |
| Jun 30, 2025 | 10.30 Mn |
| Mar 31, 2025 | 9.20 Mn |
| Dec 31, 2024 | 9.30 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 9.20 Mn |
| Mar 31, 2024 | 7.50 Mn |
| Dec 31, 2023 | 8.50 Mn |
| Sep 30, 2023 | 11.20 Mn |
| Jun 30, 2023 | 11.50 Mn |
| Mar 31, 2023 | 8.50 Mn |
| Dec 31, 2022 | 7.70 Mn |
| Sep 30, 2022 | 6.10 Mn |
| Jun 30, 2022 | 4.80 Mn |
| Mar 31, 2022 | 4.60 Mn |
| Dec 31, 2021 | 4.10 Mn |
API Access
Neurocrine Biosciences Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();